Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Airs Medical, Avance Clinical, Bioptimus, Biosig, Elephas, Lazurite, Lifecore, Medtronic, Owkin, Paragoncare, Ryght.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Diacarta, Wellvii, Werfen, X-trodes.
Researchers from the Academic Medical Center (AMC) University of Amsterdam are seeking protection for their invention of a total artificial heart which is compact, durable and mimics the natural movement of human tissue.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiodynamics, Autonomix, Intelligent Bio, Precisionlife, Spectrum Vascular, T2 Biosystems.
Despite a slowdown in the fourth quarter (Q4), med-tech deals concluded the year with the highest deal-value total in BioWorld MedTech’s records. In 2023, a total of $10.63 billion was raised from deals, a 33% increase over the $7.99 billion deal total in 2022. Meanwhile, annual M&A value dropped 58%, from $153.09 billion in 2022 to $64.8 billion in 2023.
The U.S. FDA reported Feb. 15 that Philips USA, a subsidiary of Amsterdam-based Royal Philips NV, recalled three models of the Brightview line of single photon emission CT (SPECT) systems due to an incident in which the system detector fell.
Shionogi & Co. Ltd. is partnering with Fronteo Inc. to develop artificial intelligence (AI)-based diagnostic tools to diagnose mental and neurological disorders more accurately.
RSS
